Impact of KRAS and BRAF Gene Mutation Status on Outcomes From the Phase III AGITG MAX Trial of Capecitabine Alone or in Combination With Bevacizumab and Mitomycin in Advanced Colorectal Cancer

✍ Scribed by Price, T. J.; Hardingham, J. E.; Lee, C. K.; Weickhardt, A.; Townsend, A. R.; Wrin, J. W.; Chua, A.; Shivasami, A.; Cummins, M. M.; Murone, C.; Tebbutt, N. C.

• Book ID: 125478697
• Publisher: American Society of Clinical Oncology
• Year: 2011
• Tongue: English
• Weight: 273 KB
• Volume: 29
• Category: Article
• ISSN: 0732-183X
• DOI: 10.1200/jco.2010.34.5520